Stimcell Energetics (STME) Net Income towards Common Stockholders (2016 - 2024)
Stimcell Energetics (STME) posted quarterly Net Income towards Common Stockholders of -$124957.0 for Q2 2024, down 57.41% year-over-year from -$293397.1 in Q2 2023, and down 85.0% quarter-over-quarter from -$67546.0 in Q1 2024.
Stimcell Energetics (STME) Net Income towards Common Stockholders (2016 - 2024) Analysis & Trends
Stimcell Energetics' Net Income towards Common Stockholders history runs 9 years deep, the most recent figure standing at -$124957.0 for Q2 2024.
- In Q2 2024, Net Income towards Common Stockholders fell 57.41% year-over-year to -$124957.0; the TTM figure through Feb 2025 stood at -$124957.0 (up 56.07% YoY), while the FY2024 annual figure was -$2.1 million, up 7.11% from the prior year.
- Net Income towards Common Stockholders for Q2 2024 stood at -$124957.0, down from -$67546.0 in the prior quarter.
- The five-year high for Net Income towards Common Stockholders was -$60547.0 in Q4 2023, with the low at -$356333.0 in Q1 2020.
- The 5-year median for Net Income towards Common Stockholders is -$158623.0 (2022), against an average of -$160431.2.
- Peak annual rise in Net Income towards Common Stockholders reached 78.9% in 2020, while the deepest fall reached 319.8% in 2020.
- Stimcell Energetics' Net Income towards Common Stockholders stood at -$189336.0 in 2020, then climbed by 7.06% to -$175977.0 in 2021, then grew by 18.85% to -$142813.0 in 2022, then jumped by 57.6% to -$60547.0 in 2023, then plunged by 106.38% to -$124957.0 in 2024.
- Business Quant data shows STME's Net Income towards Common Stockholders at -$124957.0 in Q2 2024, -$67546.0 in Q1 2024, and -$60547.0 in Q4 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.63 Bn | 194.02 Bn | 7.27 Bn | 928.00 Mn |
| 2 | Stryker | 127.42 Bn | 123.95 Bn | 4.50 Bn | 1.28 Bn |
| 3 | Medtronic | 118.97 Bn | 109.75 Bn | 6.41 Bn | 1.26 Bn |
| 4 | Boston Scientific | 73.39 Bn | 72.85 Bn | 3.85 Bn | 907.00 Mn |
| 5 | Edwards Lifesciences | 51.97 Bn | 47.72 Bn | 1.35 Bn | 241.40 Mn |
| 6 | Dexcom | 34.32 Bn | 32.37 Bn | 830.00 Mn | 249.10 Mn |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.65 Bn | 2.18 Bn | 574.00 Mn |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn | 621.86 Mn |
| 9 | Steris | 23.04 Bn | 22.56 Bn | 684.20 Mn | 201.00 Mn |
| 10 | Stimcell Energetics | 4.65 Mn | 4.64 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2024 | -124,957.00 |
| Feb 29, 2024 | -67,546.00 |
| Nov 30, 2023 | -60,547.00 |
| Aug 31, 2023 | -76,953.00 |
| May 31, 2023 | -79,383.00 |
| Feb 28, 2023 | -118,161.00 |
| Nov 30, 2022 | -142,813.00 |
| Aug 31, 2022 | -154,685.00 |
| May 31, 2022 | -162,561.00 |
| Feb 28, 2022 | -119,489.00 |
| Nov 30, 2021 | -175,977.00 |
| Aug 31, 2021 | -239,352.00 |
| May 31, 2021 | -187,629.00 |
| Feb 28, 2021 | -179,008.00 |
| Nov 30, 2020 | -189,336.00 |
| Aug 31, 2020 | -201,202.00 |
| May 31, 2020 | -251,830.00 |
| Feb 29, 2020 | -356,333.00 |
| Nov 30, 2019 | -303,488.00 |
| Aug 31, 2019 | -245,287.00 |